Arkolith/Insider Trading/DFFN/Form 4

Cobuzzi Robert Joseph Jr.

President & CEO, DirectorDiffusion Pharmaceuticals Inc. (DFFN) · full profile →Form 4 · filed Apr 19, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 18, 2022Conversion(C)100$25.00$3K792

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 18, 2022Conversion(C)100$25.00$3K0

Transaction Codes

C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-22-009234) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML